SCHEDULE 13G Filed 2026-06-23 Event — SEC 0001440771-26-000010 →

Stonepine Capital Management, LLC → Pasithea Therapeutics Corp. KTTAW

Stake: — Shares: — Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

10 filings by this filer

9 other filings in the data moat

Short Interest · settle 2026-09-15

DTC 3.26

26,825 shares short · -1.5% vs prior

Other 13D/G Filings on Pasithea Therapeutics Corp.

Filed	Form	Filer	Stake	Shares
2026-07-01	SCHEDULE 13G/A	Coastlands Capital LP	—	—	view →
2025-03-06	SCHEDULE	STEINMAN LAWRENCE	3.10%	83,858	view →
2022-09-01	SC	Camac Fund, LP	—	—	view →
2022-06-27	SC	Camac Fund, LP	—	—	view →

Other Filings by Stonepine Capital Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-08-31	SCHEDULE 13G	Femasys Inc	—	—	view →
2026-08-26	SCHEDULE 13G	Edesa Biotech, Inc.	—	—	view →
2026-08-25	SCHEDULE 13G	CalciMedica, Inc.	—	—	view →
2026-07-21	SCHEDULE 13G	AEON Biopharma, Inc.	—	—	view →
2026-06-22	SCHEDULE 13G	Azitra, Inc. AZTR	—	—	view →
2026-06-16	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →
2026-06-09	SCHEDULE 13G	SINTX Technologies, Inc. SINT	—	—	view →
2019-07-23	SC	VIVEVE MEDICAL, INC.	—	—	view →
2018-02-12	SC	VIVEVE MEDICAL, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →